Sorroche, B.P.; Miranda, K.C.; Beltrami, C.M.; Arantes, L.M.R.B.; Kowalski, L.P.; Marchi, F.A.; Rogatto, S.R.; Almeida, J.D.
HOXA1 3′UTR Methylation Is a Potential Prognostic Biomarker in Oral Squamous cell Carcinoma. Cancers 2024, 16, 874.
https://doi.org/10.3390/cancers16050874
AMA Style
Sorroche BP, Miranda KC, Beltrami CM, Arantes LMRB, Kowalski LP, Marchi FA, Rogatto SR, Almeida JD.
HOXA1 3′UTR Methylation Is a Potential Prognostic Biomarker in Oral Squamous cell Carcinoma. Cancers. 2024; 16(5):874.
https://doi.org/10.3390/cancers16050874
Chicago/Turabian Style
Sorroche, Bruna Pereira, Keila Cristina Miranda, Caroline Moraes Beltrami, Lidia Maria Rebolho Batista Arantes, Luiz Paulo Kowalski, Fabio Albuquerque Marchi, Silvia Regina Rogatto, and Janete Dias Almeida.
2024. "HOXA1 3′UTR Methylation Is a Potential Prognostic Biomarker in Oral Squamous cell Carcinoma" Cancers 16, no. 5: 874.
https://doi.org/10.3390/cancers16050874
APA Style
Sorroche, B. P., Miranda, K. C., Beltrami, C. M., Arantes, L. M. R. B., Kowalski, L. P., Marchi, F. A., Rogatto, S. R., & Almeida, J. D.
(2024). HOXA1 3′UTR Methylation Is a Potential Prognostic Biomarker in Oral Squamous cell Carcinoma. Cancers, 16(5), 874.
https://doi.org/10.3390/cancers16050874
